AGP Executive Report
Last update: 11 hours agoRare Childhood Brain Disease: Amsterdam UMC-led research in The Lancet Neurology suggests the existing blood pressure drug guanabenz may slow vanishing white matter progression in children, with fewer wheelchair dependencies and no deaths in the treated group. Heart Failure Treatment: UMCG cardiologists report low-dose digoxin could reduce hospitalisations and death risk in heart failure, potentially adding an affordable option to standard care. Public Health & Research Integrity: The British Medical Journal retracted a 2024 paper on COVID-era excess deaths, citing problematic discussion around causes; an internal probe found no misconduct. Drug Policy Cooperation: Ghana and the Netherlands signed a Letter of Intent to tackle illicit drugs and dismantle criminal networks behind drug markets. Emergency Care Innovation: A Dutch student team unveiled “Stella Juva,” described as the world’s first solar-powered ambulance, designed to deliver care in off-grid areas. Wildfire Health Risks: Belgium’s High Fens wildfire prompted evacuations and EU support, with smoke posing health hazards for nearby communities. Travel & Care Access: A report highlights that travel medical insurance is typically required for Schengen trips and should cover the full stay.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
